Illumina INC:1107104 -maintenance service contract for illumina nextseq 500 equipment
Ended Purchase Order Awarded Last action
- Contract number
- 75N91018P00316
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $173,062
Award facts
- Opportunity
-
- N02RC8255861 Solicitation number
- Renewal of a Maintenance Agreement for NextSeq 500, Serial numbers: NSQ-NS500348 and NSQ-NS500391. Award Notice · Posted Apr 25, 2018
- Contract value 58% obligated
-
- $173,062.00 Current, with exercised options
- $300,280.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 811219 Other Electronic and Precision Equipment Repair and Maintenance
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $59,964 | |
| Other Administrative Action | $57,658 | |
| Original award | $55,440 |
About this award
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed price purchase order contract valued at $300,280.00 to Illumina, Inc. for maintenance services on Illumina NextSeq 500 genomic sequencing equipment. The contract has a completion date of May 18, 2023 and was awarded on May 19, 2018. Illumina, a for-profit manufacturer of genomic analysis instruments and reagents, has been awarded numerous prime and subcontract federal awards from agencies like the NIH, CDC, USDA, and VA to provide sequencing systems, consumables, and support services for genomics research and diagnostics applications. This contract appears to be a standalone maintenance service agreement and does not utilize any set-aside provisions.
Quick answers
Who was awarded contract 75N91018P00316?
75N91018P00316 was awarded to Illumina, Inc. by National Cancer Institute (National Institutes of Health) on May 19, 2018.
How much is contract 75N91018P00316 worth?
The government has obligated $173,062 on 75N91018P00316. Its potential value, with all options, is $300,280.
Was contract 75N91018P00316 competed?
The extent of competition for 75N91018P00316 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award